Indian benchmark indices extended their losing streak for a fourth consecutive session on Thursday. Nifty 50 fell 0.17% and Sensex declined...

The BSE Sensex ended at 76,944.28, lower by 12.99 points or 0.02%, as gains in IT, FMCG and select heavyweights helped limit the fall.

Indian midcap and smallcap indices are near record highs currently. A few select stocks are driving most of these significant gains. This c...

Mutual funds bought Rs 15,900 crore of stocks in July while FIIs sold Rs 11,000 crore. Axis Bank, INDO-MIM and Kotak Mahindra Bank saw majo...

Indian equities declined as rising crude prices and a weaker rupee weighed on sentiment. Sensex fell 388 points and Nifty 112 points, while...

Gland Pharma shares rose sharply after Q1FY27 profit rose 47% and revenue grew 20% year-on-year. While strong margins and CDMO growth promp...

For Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...

Goldman Sachs expects the Nifty 50 to rebound to 26,500 by June 2027, above its current record high, as India’s macro backdrop improves. Lo...

Nearly 90 companies, including Jio Financial Services, Power Grid Corporation, HPCL, and Hindustan Aeronautics, will turn ex-dividend betwe...

Mutual funds invested Rs 50,600 crore in stocks during June. They significantly bought JSWInfra, Bajaj Finance, and HDFC Bank. Conversely, ...

Quant Small Cap Fund made a major portfolio reshuffle in June, exiting Reliance Industries and eight other stocks while increasing exposure...

Indian equities ended lower after four straight gains as profit booking, weak global cues and caution ahead of the US Fed minutes weighed o...

Our technical analysts identify select stocks every trading day that may gain momentum even in volatile markets. Here are the technical cal...

Indian equities declined for a second session as investors stayed cautious despite easing geopolitical tensions. Sensex lost nearly 250 poi...

Indian equity markets are experiencing a cautious phase, consolidating within a defined range as fresh buying momentum remains elusive. Tec...

Global brokerage firm Jefferies upgraded Gland Pharma's stock to buy from underperform with an increased price target of Rs 1,640 from Rs 1...

Another domestic brokerage firm Nirmal Bang Institutional Equities has cut its revenue and EBITDA estimates for the next three fiscals due ...